China Shijiazhuang Pharmaceutical Group Co., Ltd. ( China (Mainland))

China Shijiazhuang Pharmaceutical Group Co., Ltd. was incorporated by Hebei Pharmaceutical Corporation, Shijiazhuang No. 1 Pharmaceutical Group Co., Ltd. and other two companies on Aug 21, 1997. It’s the first mega pharmaceutical enterprise jointly established by big pharmaceutical enterprises in the medicine industry of China, and it’s also one of the pillar enterprise group of Hebei Province. China Pharmaceutical Group Co., Ltd., one of controlling affiliates, listed in Hong Kong and one of the Hang Seng Red Chips Index Component stocks, and has been named by world-known Forbes as one of Top 100 Listed Companies.

CSPC Pharma. is mainly engaged in pharmaceutical product development, production and sale. Its key products include antibiotic, vitamin, cardiovascular and cerebrovascular medicine, antipyretic and analgesic drug and respiratory drug, etc, six series in total and nearly 1,000 varieties, and penicillin series and vitamin series are its dominant products such as Vitamin C (50-81-7), Amoxicillin (26787-78-0), 7-Aminocephalosporanic acid (957-68-6), Caffeine (58-08-2). CSPC Pharma. has applied for 200 patents, including more than 10 PCT international patents.

CSPC Pharma. has have achieved GMP certification, and all the subordinated companies have passed ISO9000, OHSAS18000 and ISO14001 certifications. Meanwhile, CSPC Pharma. has been engaged in improving the quality connotation by technology, and 6 pharmaceutical products have achieved COS certification of EU, and obtained a “passport” to the high-end markets in Europe and America.

CSPC boasts two “Well-known Trademarks of China”, i.e. “CSPC” and “Ouyi”; “CSPC” was assessed by World Brand Lab (WBL), one of the world’s five major brand evaluation organizations, and named one of “Top 500 Most Valuable Chinese Brands 2005”; CSPC has been selected “Top 500 Chinese Enterprises” for three successive times and won the title “Chinese Enterprises with the Most Valuable Brand 2008”.